Showing 1061-1070 of 3039 results for "".
- AAFPRS President Outlines “Three Rs” of Facial Plastic Surgeryhttps://modernaesthetics.com/news/aafprs-president-outlines-three-rs-of-facial-plastic-surgery/2485394/As patient interest in facial aesthetic and reconstructive procedures continues to grow, the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is emphasizing the importance of specialty training through a new public education framework: the “Three Rs of the AAFPRS:” rhinoplas
- Dr. Sam Rizk to Present Deep Plane Facelift Technique at Final Baker Gordon Symposiumhttps://modernaesthetics.com/news/dr-sam-rizk-to-present-deep-plane-facelift-technique-at-final-baker-gordon-symposium/2485393/The Baker Gordon Plastic Surgery Symposium will hold its 60th and final gathering February 5-7 in Miami. Among the invited faculty is Dr. Sam Rizk, who will present his deep plane facelift technique, reflecting the procedure’s continued evolution toward natural, long-lasting results. Dr. R
- skinbetter science® Marks 10 Years of AlphaRet® Technology in Retinoid-AHA Skincarehttps://modernaesthetics.com/news/skinbetter-science-marks-10-years-of-alpharet-technology-in-retinoid-aha-skincare/2485358/skinbetter science® is marking the 10-year anniversary of its proprietary AlphaRet® technology, introduced in 2016 as one of the first topical skincare formulas to combine a retinoid with an alpha hydroxy acid (AHA). The combination, used in the flagship AlphaRet Overnight Cream, was designed to
- FDA Approves RHA® Dynamic Volume for Midface Augmentationhttps://modernaesthetics.com/news/fda-approves-rha-dynamic-volume-for-midface-augmentation/2485309/The US Food and Drug Administration (FDA) has approved RHA® Dynamic Volume from the Teoxane RHA® Collection for cheek augmentation and correction of age-related midface contour deficiencies in adults 22 and older, Revance and Teoxane announced.
- FDA Approves Once-Daily Oral Semaglutidehttps://modernaesthetics.com/news/fda-approves-once-daily-oral-semaglutide/2485258/The US Food and Drug Administration (FDA) has approved Novo Nordisk’s once-daily oral formulation of semaglutide, marketed as Wegovy® pill, marking the first oral GLP-1 receptor agonist approved for chronic weight management in the United States. The approval includes indications for adults with
- Exosome Skin Booster Plus Microneedling Shows High Satisfaction in Retrospective Reviewhttps://modernaesthetics.com/news/exosome-skin-booster-plus-microneedling-shows-high-satisfaction-in-retrospective-review/2485225/A retrospective analysis published in Plastic and Aesthetic Nursing evaluated the clinical outcomes of an exosome-containing skin booster combined with microneedling for facial rejuvenation, reporting high patient satisfaction and favorable safety findings.<
- Dual Biologic Therapy Promotes Hair Follicle Regeneration in Preclinical Studyhttps://modernaesthetics.com/news/dual-biologic-therapy-promotes-hair-follicle-regeneration-in-preclinical-study/2485066/New preclinical research suggests that combining botulinum neurotoxin type A (BoNT/A) with platelet-rich plasma (PRP) may synergistically promote hair follicle regeneration through activation of the Wnt/β-catenin signaling pathway and modulation of stathmin 1 (STMN1) protein expression. The findi
- Senolytic Skincare Platform Backed by First Peer-Reviewed Studyhttps://modernaesthetics.com/news/senolytic-skincare-platform-backed-by-first-peer-reviewed-study/2485088/Robles BioCeutics, a regenerative dermatology company focused on senolytic and stem cell–inspired approaches, has published its first peer-reviewed article in The Journal of Translational Medicine, validating the scientific basis of its proprietary skin regeneration platform. The
- New Anatomical Model Enhances Understanding of Eyelid Dynamics in Blepharoplastyhttps://modernaesthetics.com/news/new-anatomical-model-enhances-understanding-of-eyelid-dynamics-in-blepharoplasty/2485032/A recent anatomic investigation offers new insight into the biomechanical dynamics of upper eyelid movement, with potential implications for optimizing blepharoplasty outcomes and improving complication management. The study, published in Aesthetic Plastic Surgery, combines clinical, cad
- Hypermobility Not a Factor in Rhinoplasty Satisfaction, Study Suggestshttps://modernaesthetics.com/news/hypermobility-not-a-factor-in-rhinoplasty-satisfaction-study-suggests/2484897/A recent case-control, cross-sectional study published in Journal of College of Physicians and Surgeons Pakistan (JCPSP) finds that joint hypermobility (JH) does not affect satisfaction or outcomes in patients undergoing rhinoplasty, suggesting that rou